| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Wound Healing Research and Glaucoma Units, Moorfields Eye Hospital and Institute of Ophthalmology, London, United Kingdom.
Abstract
PURPOSE. Currently available anti-scarring regimens for glaucoma filtration surgery have potentially blinding complications and thus the need for alternative and safer agents. The effects of a new antibody to transforming growth factor (TGF)-ß2 on in vitro and in vivo conjunctival scarring and after glaucoma filtration surgery were investigated.
METHODS. The activity of a novel recombinant monoclonal neutralizing antibody (mAb) to human TGF-2 (rhAnti-TGF-ß2 mAb) was studied in conjunctival fibroblast-mediated proliferation, migration, and collagen contraction. Its safety in subconjunctival administration was assessed in vivo, and, in a rabbit model of glaucoma filtration surgery, its effects on conjunctival scarring and filtration surgery outcome were investigated.
RESULTS. The rhAnti-TGF-ß2 mAb effectively inhibited TGF-ß2–mediated conjunctival scarring activity in vitro, at 50% inhibitory concentrations (IC50) of less than 1 nM. It significantly improved glaucoma filtration surgery outcome in an animal model of aggressive conjunctival scarring compared with control (P = 0.0291) and was clinically safe, nontoxic, and well tolerated after subconjunctival administration.
CONCLUSIONS. Subconjunctival rhAnti-TGF-ß2 mAb treatment significantly affects surgical outcome and effectively reduces conjunctival scarring both in vitro and in vivo. It appears safe for subconjunctival administration and when compared with mitomycin-C treatment histologically, much less destructive to local tissue. rhAnti-TGF-ß2 mAb may have potential as a new anti-scarring agent for use in glaucoma filtration surgery.
This article has been cited by other articles:
|
|
 |
|
  L. Guo, T. E. Salt, V. Luong, N. Wood, W. Cheung, A. Maass, G. Ferrari, F. Russo-Marie, A. M. Sillito, M. E. Cheetham, et al. Targeting amyloid-beta in glaucoma treatment PNAS, August 14, 2007; 104(33): 13444 - 13449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-A. Jung, H. K. Lee, J. S. Yoon, S.-J. Kim, C. Y. Kim, H. Song, K.-C. Hwang, J. B. Lee, and J. H. Lee Upregulation of TGF-{beta}-Induced Tissue Transglutaminase Expression by PI3K-Akt Pathway Activation in Human Subconjunctival Fibroblasts Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 1952 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tura, S. Grisanti, K. Petermeier, and S. Henke-Fahle The Rho-Kinase Inhibitor H-1152P Suppresses the Wound-Healing Activities of Human Tenon's Capsule Fibroblasts In Vitro Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2152 - 2161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Meyer-ter-Vehn, S. Sieprath, B. Katzenberger, S. Gebhardt, F. Grehn, and G. Schlunck Contractility as a Prerequisite for TGF-{beta}-Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4895 - 4904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priglinger, C. S. Alge, D. Kook, M. Thiel, R. Schumann, K. Eibl, A. Yu, A. S. Neubauer, A. Kampik, and U. Welge-Lussen Potential role of tissue transglutaminase in glaucoma filtering surgery. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3835 - 3845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Lois, J. Taylor, A. D. McKinnon, G. C. Smith, R. van't Hof, and J. V. Forrester Effect of TGF-{beta}2 and Anti-TGF-{beta}2 Antibody in a New In Vivo Rodent Model of Posterior Capsule Opacification Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4260 - 4266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Guo, S. E. Moss, R. A. Alexander, R. R. Ali, F. W. Fitzke, and M. F. Cordeiro Retinal Ganglion Cell Apoptosis in Glaucoma Is Related to Intraocular Pressure and IOP-Induced Effects on Extracellular Matrix Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 175 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Grisanti, P. Szurman, M. Warga, R. Kaczmarek, F. Ziemssen, O. Tatar, and K. U. Bartz-Schmidt Decorin Modulates Wound Healing in Experimental Glaucoma Filtration Surgery: A Pilot Study Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Esson, M. P. Popp, L. Liu, G. S. Schultz, and M. B. Sherwood Microarray Analysis of the Failure of Filtering Blebs in a Rat Model of Glaucoma Filtering Surgery Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4450 - 4462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Eibl, B. Banas, D. Kook, A. V. Ohlmann, S. Priglinger, A. Kampik, and U. C. Welge-Luessen Alkylphosphocholines: A New Therapeutic Option in Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2619 - 2624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Jackson and J. Marshall Fluorophore-Assisted Retinal Break Detection Using Antibodies to Glial Fibrillary Acidic Protein Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 993 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Esson, A. Neelakantan, S. A. Iyer, T. D. Blalock, L. Balasubramanian, G. R. Grotendorst, G. S. Schultz, and M. B. Sherwood Expression of Connective Tissue Growth Factor after Glaucoma Filtration Surgery in a Rabbit Model Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 485 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Mead, T. T. L. Wong, M. F. Cordeiro, I. K. Anderson, and P. T. Khaw Evaluation of Anti-TGF-{beta}2 Antibody as a New Postoperative Anti-scarring Agent in Glaucoma Surgery Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3394 - 3401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Blalock, M. R. Duncan, J. C. Varela, M. H. Goldstein, S. S. Tuli, G. R. Grotendorst, and G. S. Schultz Connective Tissue Growth Factor Expression and Action in Human Corneal Fibroblast Cultures and Rat Corneas after Photorefractive Keratectomy Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1879 - 1887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Razzaque, C. S. Foster, and A. R. Ahmed Role of Collagen-Binding Heat Shock Protein 47 and Transforming Growth Factor-{beta}1 in Conjunctival Scarring in Ocular Cicatricial Pemphigoid Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1616 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. L. Wong, A. L. Mead, and P. T. Khaw Matrix Metalloproteinase Inhibition Modulates Postoperative Scarring after Experimental Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1097 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Daniels, A. D. Cambrey, N. L. Occleston, Q. Garrett, R. W. Tarnuzzer, G. S. Schultz, and P. T. Khaw Matrix Metalloproteinase Inhibition Modulates Fibroblast-Mediated Matrix Contraction and Collagen Production In Vitro Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1104 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.F. Cordeiro, F. Kuwahara, H. Kai, K. Tokuda, T. Imaizumi, M. Kai, A. Takeshita, and K. Egashira Transforming Growth Factor-{beta} Function Blocking Already Effective as Therapeutic Strategy * Response Circulation, February 11, 2003; 107 (5): e37 - e37. [Full Text] [PDF]
|
|
|
|
 |
|
 J R Fuller, T H Bevin, A C B Molteno, B J T Vote, and P Herbison Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure produces good long term control of intraocular pressure without risk of sight threatening complications Br. J. Ophthalmol., December 1, 2002; 86(12): 1352 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Crystal, P. B. Bitterman, B. Mossman, M. I. Schwarz, D. Sheppard, L. Almasy, H. A. Chapman, S. L. Friedman, T. E. King Jr., L. A. Leinwand, et al. Future Research Directions in Idiopathic Pulmonary Fibrosis: Summary of a National Heart, Lung, and Blood Institute Working Group Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 236 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Wormstone, S. Tamiya, I. Anderson, and G. Duncan TGF-{beta}2-Induced Matrix Modification and Cell Transdifferentiation in the Human Lens Capsular Bag Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2301 - 2308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Perkins, B. Faha, M. Ni, J. A. Kiland, G. L. Poulsen, D. Antelman, I. Atencio, J. Shinoda, D. Sinha, L. Brumback, et al. Adenovirus-Mediated Gene Therapy Using Human p21WAF-1/Cip-1 to Prevent Wound Healing in a Rabbit Model of Glaucoma Filtration Surgery Arch Ophthalmol, July 1, 2002; 120(7): 941 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P T Khaw, A D Cambrey, G A Limb, and J T Daniels Gene therapy: new "magic bullets" to prevent ocular scarring Br. J. Ophthalmol., May 1, 2002; 86(5): 490 - 492. [Full Text] [PDF]
|
|
|
|
|
|
G. J. Angella, M. B. Sherwood, L. Balasubramanian, J. W. Doyle, M. F. Smith, G. van Setten, M. Goldstein, and G. S. Schultz Enhanced Short-Term Plasmid Transfection of Filtration Surgery Tissues Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4158 - 4162. [Abstract] [Full Text]
|
|
|
|
|
|
J. M LIEBMANN and R. RITCH Bleb related ocular infection: a feature of the HELP syndrome Br. J. Ophthalmol., December 1, 2000; 84(12): 1338 - 1339. [Full Text]
|
|
|
|
 |
|
 G. C. Blobe, W. P. Schiemann, and H. F. Lodish Role of Transforming Growth Factor {beta} in Human Disease N. Engl. J. Med., May 4, 2000; 342(18): 1350 - 1358. [Full Text] [PDF]
|
|
|
|
|
|
L. Carrington, D. McLeod, and M. Boulton IL-10 and Antibodies to TGF-{beta}2 and PDGF Inhibit RPE-Mediated Retinal Contraction Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1210 - 1216. [Abstract] [Full Text]
|
|
|
|
|
|
M F. CORDEIRO, G. S SCHULTZ, R. R ALI, S. S BHATTACHARYA, and P. T KHAW Molecular therapy in ocular wound healing Br. J. Ophthalmol., November 1, 1999; 83(11): 1219 - 1224. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
